Cite
HARVARD Citation
Rosenstock, J. et al. (n.d.). Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial. Diabetes, obesity & metabolism. 17 (10), pp. 936-948. [Online].